Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Celltrion decided to convene its 34th Annual General Meeting of Shareholders on March 25, 2025, to vote on agenda items including financial statement approval, capital reserve reduction, and the re-election of Chairman Seo Jung-jin as a director.
📊 Key Disclosure Content & Financial Highlights
- Overview
- Company: Celltrion, Inc. (Stock Code: 068270)
- Disclosure Type: Decision on Convening General Meeting of Shareholders
- Meeting Type: Annual General Meeting (AGM)
- Date & Time: 2025-03-25 at 10:00 KST
- Location: 2nd Floor, Songdo Convensia, 123 Central-ro, Yeonsu-gu, Incheon, South Korea
- Board Resolution Date: 2025-02-25 (8 Outside Directors attended)
- Key Reporting Matters & Agenda Items
- Reporting Items:
- FY2024 Audit Report & Business Report
- FY2024 (Consolidated & Separate) Internal Accounting Control System Operation Status Report
- Agenda Items for Approval:
- Item 1: Approval of FY2024 Financial Statements
- Item 2: Approval of Reduction in Capital Reserves
- Item 3: Election of Director (Re-election of Seo Jung-jin, Chairman of the Board / 2-year term)
- Item 4: Approval of Remuneration Limit for Directors
- Item 5: Approval of Amendments to Executive Retirement Allowance Regulations
- Corporate Governance & Other Details
- The Audit Committee consists entirely of Outside Directors.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of AGM Voting Results on Agenda Items
This disclosure serves as official notification regarding the call for the 34th Annual General Meeting of Shareholders and its proposed agenda. Reviewing whether key items—such as financial statement approval, capital reserve reduction, and director elections—are passed as proposed on the meeting date is important for evaluating the final confirmation of financial results and corporate governance decisions. Relevant details can be confirmed through the subsequent disclosure on AGM voting results.
📢 Disclaimer & Source Notice
Source: This content was structured and generated based on official disclosure data from the Financial Supervisory Service’s DART system.
Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
